Back
Evoke Pharma Vs. Repligen Industry Stock Comparison
Sell
13
EVOK
Evoke Pharma
Last Price:
4.35
Seasonality Move:
12.83%
Buy
62
RGEN
Repligen
Last Price:
147.98
Seasonality Move:
9.8%
Sell
13
Evoke Pharma (EVOK)
is a Sell
Is Evoke Pharma a Buy, Sell or Hold?
- The current Evoke Pharma [EVOK] share price is $4.30. The Score for EVOK is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- EVOK is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
62
Repligen (RGEN)
is a Buy
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $150.43. The Score for RGEN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- RGEN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EVOK Stock Price Chart
What is Evoke Pharma's stock price today?
-
The Evoke Pharma share price today is $4.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVOK is experiencing slight selling pressure.
RGEN Stock Price Chart
EVOK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 34.35 | Sell |
| Chaikin Money Flow: | -79625 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.97 - 6.05) | Sell |
| Bollinger Bands (100): | (4.55 - 6.21) | Sell |
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.24 | Buy |
| Relative Strength Index (14 RSI): | 60.5 | Buy |
| Chaikin Money Flow: | 267924 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (135.86 - 145.78) | Buy |
| Bollinger Bands (100): | (129.63 - 153.59) | Buy |
EVOK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.42 | Sell |
| 20-day SMA: | 5.6 | Sell |
| 50-day SMA: | 5.06 | Sell |
| 200-day SMA: | 6.08 | Sell |
| 8-day EMA: | 5.26 | Sell |
| 20-day EMA: | 5.44 | Sell |
| 50-day EMA: | 5.33 | Sell |
| 200-day EMA: | 7.36 | Sell |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 144.33 | Buy |
| 20-day SMA: | 141.13 | Buy |
| 50-day SMA: | 141.65 | Buy |
| 200-day SMA: | 158.16 | Sell |
| 8-day EMA: | 144.41 | Buy |
| 20-day EMA: | 142.18 | Buy |
| 50-day EMA: | 142.4 | Buy |
| 200-day EMA: | 151.66 | Sell |
Evoke Pharma Earnings Growth & EVOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.24 per share.
Evoke Pharma Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Repligen Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||